Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
IASLC Academy
IASLC Academy
Amazing Case Race 2024
Publications, Resources & Guidelines
News
News
ILCN
WCLC 2024 News
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 169 - 180 items out of 283 results
ILCN article
A Look at Veliparib Plus Chemotherapy for First-Line Treatment of Advanced NSCLC
ILCN article
TIL Therapy Endures for Carefully Selected Patients: A Q&A with Dr. Benjamin C. Creelan
ILCN article
Early Palliative Care: A European Perspective
ILCN article
As Treatment Options in Lung Cancer Have Expanded, so Have Costs
ILCN article
Small, High PLCG2-Expressing Intratumoral Cells May Drive Metastasis
ILCN article
COAST Data Support Further Research of Immunotherapy Combinations
ILCN article
Alternative Dosing Strategies for Immune Checkpoint Inhibitors
ILCN article
Panel Explores Emerging Treatments and Sequencing Strategies for Patients with Advanced NSCLCs Driven by Rare Oncogenes
ILCN article
Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System
ILCN article
Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates
ILCN article
Using Comparative Effectiveness Data Based on Non-Randomized Study Designs to Support Regulatory, Reimbursement Decision-Making
ILCN article
In Measuring Outcomes, a Longer-Term View May be Needed
Pagination
First
First page
‹
Previous page
…
11
12
13
14
15
16
17
18
19
…
›
Next page
Last
Last page